アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

mundipharma a/s - fluticasonum própíónat; formoterolum fúmarat - innúðalyf, dreifa - 50 míkróg/5 míkróg

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - fluticasonum própíónat; salmeterolum xínafóat - innöndunarduft, afmældir skammtar - 50/250 míkróg/skammt

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - fluticasonum própíónat; salmeterolum xínafóat - innöndunarduft, afmældir skammtar - 50/500 míkróg/skammt

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris aps - azelastinum hýdróklóríð; fluticasonum própíónat - nefúði, dreifa - 137 míkróg / 50 míkróg/skammt

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - lopinavir, rítónavír - hiv sýkingar - antivirals for systemic use, protease inhibitors - kaletra er ætlað ásamt öðrum antiretroviral lyf til meðferð hiv veira (hiv-1) sýkt fullorðnir, unglingum og börn á aldrinum 14 daga og eldri. val á kaletra að meðhöndla próteasahemla upplifað hiv-1 sýkt sjúklingar ætti að vera byggt á einstökum veiru mótstöðu próf og meðferð sögu af sjúklingum.

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - salmeterolum xínafóat; fluticasonum própíónat - innúðalyf, dreifa - 25/250 míkróg/skammt

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - salmeterolum xínafóat; fluticasonum própíónat - innúðalyf, dreifa - 25/125 míkróg/skammt

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

glenmark pharmaceuticals nordic ab* - salmeterolum xínafóat; fluticasonum própíónat - innöndunarduft, afmældir skammtar - 50 míkróg/500 míkróg/skammt